This site is intended for healthcare professionals only
LoginRegister
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresJnJ chemotherapy free lung cancer treatment Rybrevant plus Lazcluze gets USFDA okay
NPPA Finally Allows GSK to Discontinue Grisovin FPGSK secures USFDA Breakthrough Therapy Designation for GSK5764227 for extensive stage small cell...
Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid TariffsJohnson & Johnson to acquire V-Wave
NPPA Expert Committee Recommends Pricing for Abbotts Clarithromycin Tablet, Cautions Firm Over Form ErrorNPPA Fixes Retail Prices of 70 Formulations, Details
Marksans Pharma arm gets marketing nod for Cetirizine Dihydrochloride 1 mg/ml Oral Solution in UKUSFDA issues EIR for Marksans Pharma Goa facility
After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug NereusGranules India bags USFDA okay for Glycopyrrolate Oral Solution
Aurobindo Pharma China Plant incurring loss, break even expected by Q4Aurobindo Pharma China plant expected to be commercialised from Q3 FY25: CFO
Groundbreaking digital platforms, Indian Pharmacopoeia online portal, Adverse Drug Reaction Monitoring System software launched at First Policy Makers ForumGroundbreaking digital platforms, Indian Pharmacopoeia online portal, Adverse Drug Reaction...
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsStrides Pharma Science arm gets USFDA EIR for Alathur facility
Pfizer Awards Rs 60 Lakh Each to 14 Healthtech Startups Under INDovation 2025Submit diagnosis criteria for lower respiratory infection and earlier study data: CDSCO Panel Tells...
CDSCO Clears AstraZenecas Imfinzi (Durvalumab) for Additional Cancer Indication in IndiaCDSCO Panel Approves AstraZeneca's protocol amendment proposal for COPD drug Tozorakimab
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca gets USD 107 million Pfizer verdict overturned in US cancer drug patent fight
X